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Abstract
Background: Cardiovascular disease (CVD) is considered a public health burden and most common cause of
mortality in all over the world. The latency time for developing CVD may be several decades. the objective of this
study was to examine the relationship between body composition and Left Ventriculare Mass Index (LVMI) in newly
diognosed hypertensive patients.
Methods: We enrolled 120 new-diagnosed hypertensive patients (mean age 45 ± 8 years) who admitted to our
nephrology clinic. Body fat percentage (BFP) was measured by bioelectrical impedance (BIA). Echocardiography
examinations were performed for all patients.
Results: Mean values of Waist hip ratio, Body mass ındex, Body fat percentage, Systolic blood pressure, Diastolic
blood pressure were significantly higher for females than males (all p values <0.05). The female patients had higher
LVMI than male patients (94.8 ± 13.1 vs 89.2 ± 14.6, p < 0.05). The study patients were divided into 3 groups
according to their BFP defined by BIA. Group 3 patients, who exhibited higher body fat, had significantly higher
BMI (p < 0,05), total leukocyte count (p < 0.05), CRP (p < 0.05), triglyceride (p < 0.05), and female predominance.
Group 3 patients were statistically older than group 1 patients (46.2 vs. 40.6 years, p < 0.05). Additionally, LVMI levels
were higher in Group 3 than Group 1 (p < 0.05) (Table 3). In logistic regression analysis, independent factors
affecting LVMI were age, weight, gender and BFP (all p values were <0.05).
Conclusions: BFP was associated with higher LVMI, in newly diognosed hypertensive patients. Its use results in
significantly lower proportions of individuals with LVH in the population, in particular among hypertensive and the
obese patients.
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Background
Cardiovascular disease (CVD) is considered a public
health burden and most common cause of mortality in
all over the world [1]. The risk increases continuously as
left ventricular (LV) mass rises, with no indication of a
threshold to clearly separate normal from abnormal LV
mass dimensions [2]. When defining the range of normal
LV mass, individual body size and composition must be
taken into consideration because metabolic demand and
perfusion needs vary with stature and determine the
physiological adaptation of heart size. The latency time
for developing CVD may be several decades [3]. Thus,
early risk markers are needed to identify obese subjects
at risk.
Obesity is a rapidly growing disease that is character-
ized by an excessive accumulation of adipose tissue [4].
LV mass was commonly indexed to body surface area
(BSA) [5–8]. However, the assessment of Body Fat
Percentage (BFP) in larger studies has long been ham-
pered by technical impediments. The advent of bioelec-
trical impedance analysis (BIA) now provides a validated
and easily applicable method of measuring BFP [9, 10].
BFP was analysed by BIA measurement.* Correspondence: sebnemkarakan@gmail.com1Department of Nephrology, Dr Abdurrahman Yurtaslan Oncology Training
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Finally, the objective of this study was to examine the
relationship between body composition and LVMI in
newly diognosed hypertensive patients.
Methods
We enrolled 120 new-diagnosed hypertensive patients
(mean age 45 ± 8 years, 60 males) who were admitted to
our nephrology clinic. Study exclusion criteria were anti-
hypertensive (present or past) drug use, diabetes mellitus
(current use of anti-diabetic medications, a fasting blood
glucose level of more than 126 mg/dl, and/or a random
blood glucose level of more than 200 mg/dl or hemoglobin
a1c > 6.2 %), severe or secondary hypertension (≥210/
130 mmHg), all endocrinological disorders (hyperparathyr-
oıdısm, Addison's disease etc ..), renal failure (serum cre-
atinine > 1.5 mg/dl), heart failure, peripheral or cerebral
vascular disease, cancer and hepatic disease. After at least
5 min of rest in a sitting position, office BP was measured
for all patients for bilateral arms using a sphygmomanom-
eter with the appropriate cuff size. Three BPs were mea-
sured at least 5 min apart and the mean BP was used for
analysis. Weight, height and waist circumference were de-
termined for each subject; waist circumference was mea-
sured at the narrowest diameter between the costal margin
and the iliac crest. Height (m) and weight (kg) were mea-
sured with the patient dressed in light clothing and with-
out shoes. Body mass index (BMI) was calculated by the
weight kilograms divided by the square of the height in
meters. Blood samples were obtained after nocturnal fast-
ing the same week as when 24-h ABPM was initiated.
Blood chemistry were determined by standard methods.
The study was approved by the local scientific ethics com-
mittee. The patients were enrolled after providing their in-
formed consent.
All patients were analyzed by ambulatory blood pres-
sure monitoring (ABPM) was recorded using the Oscar
(Sun Tech Medical). The data were considered ad-
equate when a minimum of 70 valid records were ob-
tained in 24 h, with at least two records per hour
during the nighttime. The following parameters were
evaluated: average 24-h, daytime and nighttime systolic
BP (SBP) and diastolic BP (DBP). Body fat percentage
(BFP) was measured by bioelectrical impedance (BIA).
Body composition and BIA data were obtained using
the Metron BioScan 916 v3 analyzer. The first pair of
electrodes was placed in the hand with the inner elec-
trode attached to the dorsum of the wrist and the outer
electrode attached to the dorsal surface of the third
metacarpal bone. The second pair of electrodes was
placed in the ipsilateral foot, with the electrodes placed
on the anterior surface of the ankle and the dorsal
surface of the third metatarsal bone. A single fre-
quency, low-amplitude imperceptible current (0.7 mA
at 50 kHz) was introduced via the outer electrodes.
Body fat was calculated by subtracting FFM from
total body weight (in kilograms).
Echocardiography
Echocardiography examinations were performed with a
2D, M-Mode, pulse wave Doppler, and tissue Doppler
echocardiography by using a Hewlett Packard, Sonos 7500,
Andover (Massachusetts, USA) with a 2.8 MHz probe.
Conventional echocardiography (M-mode and cPWD)
measurements were performed according to American
Society of Echocardiography guidelines [11]. Myocardial
velocity profiles of the lateral mitral annulus were obtained
by placing a 6 mm sample volume at the junction of the
mitral annulus and lateral myocardial wall. Left ventricular
mass (LVM) was calculated using the Devereux Formula
[19]: LVM= 0.8(1.04(IVST + LVID + LPWT)3 – (LVID)3 +
0.6), where IVST = interventricular septal thickness,
LVID = left ventricular internal dimension, and LPWT=
left posterior wall thickness. The left ventricular mass
index (LVMI) was calculated by the formula, LVM/
(height)2.7 [11]. Statistical Analysis
Descriptive statistics are presented as mean ± SD.
Continuous variables were tested to detect substantial
deviations from normality by computing the Kolmogorov-
Smirnov Z. The assumption of satisfactory normal distri-
bution was met for all of the examined variables. Pearson
correlation coefficients were used to explore the bivariate
associations between examined variables and partial pear-
son correlation coefficients were used when appropriate.
Stepwise multiple linear regression models were con-
structed using important covariates (weight, age, sex, BFP,
waist) from correlation analyses to elucidate independent
determinants of LVMI.
The minimum required sample size is calculated as 103
patients with anticipated effect size (f2) of 0.15, statistical
power of 0.80 and 7 predictors. For all of the ana-
lyses, p levels < 0.05 were considered statistically signifi-
cant. The data was analyzed using SPSS for Windows
(version 16.0; SPSS Inc., Chicago, IL, USA).
Results
A total of 120 new-diagnosed hypertensive patients
(mean age 45 ± 8 years, 60 males) were included in the
study. The demographic and clinical characteristics of
the recipients are presented in Table 1. We investigated
the relationship between body fat, inflammation, and la-
boratory parameters separately for males and females.
Mean values of WHR, BMI, BFP, SBP, DBP were signifi-
cantly higher for females than males (all p values <0.05).
The female patients had higher LVMI than male patients
(94,8 ± 13,1vs. 89,2 ± 14,6, p < 0.05).
The study patients were divided into 3 groups accord-
ing to their BFP defined by BIA (Table 2). Group 1
(BFP:<26 %, n = 30) comprised the patients in the lowest
Karakan and Inan Clinical Hypertension  (2015) 21:23 Page 2 of 5
tertile of low BFP; group 2 (BFP = 26 to 48 %, n = 60),
patients in the middle tertile; and group 3 (BFP > 48 %,
n = 30), patients in the upper tertile. Group 3 patients,
who exhibited ≥48 % of body fat, had significantly higher
BMI (p < 0.05), total leukocyte count (p < 0.05), CRP
(p < 0.05), triglyceride (p < 0.05) and female predominance.
Group 3 patients were statistically older than group 1 pa-
tients (46,2 vs. 40,6 years, p < 0.05). Additionally, LVMI
levels were higher in Group 3 than Group 1 (0.69 vs 0.65,
p < 0.05) (Table 2).
Mean LVMI were calculated as 91,4 ± 18,6 g/m2. Pearson
correlation analysis was performed and BMI (r = 0.478,
p = 0.01), systolic blood pressure (r = 0.621, p = 0.04),
BFT (r = 0.493, p = 0.03) were positively and hemoglobin
(r = -0.405, p = 0.02), ejection fraction levels (r = -0.288,
p = 0.04) were negative correlated with LVMI. The criteria
for the distinction of individuals with and without LVH
differed considerably by sex. Partition value based on in-
dexation to BFP was higher for women than for men.
In logistic regression analysis, we have converted con-
tinuous LVMI variable into categorical variable as high
(above 91 g/m2) and low (91 and below g/m2). The cut-
off value was arbitrarily chosen from the mean value of
LVMI in the study population. Independent factors af-
fecting LVMI were age, weight, and BFP (all p values
were <0.05, Table 3).
Discussion
In our study, we investigated the influence of body fat
composition on CV risk parameters in a group of
hypertensive patients. Body fat distribution is associated
with increased long-term mortality and morbidity risk,
as shown in several recent studies [12, 13]. BIA is an
adequate and easily accessible clinical tool for monitor-
ing nutritional status in patients. We observed a direct
correlation between bioimpedance measures and the
traditional anthropometric and laboratory markers of
cardiovascular risks in new-diagnosed hypertension
patients.
BFP and BMI were significantly higher for females than
males in our study (Table 1). The most important and
drastic gender differences in BFP are related to reproduct-
ive functions that change through the age [14, 15].
We found that higher BMI and BFP were associated
with higher LVMI. These data are in line with epidemio-
logic studies showing that Central body fat distribution
is an independent risk factor for CVR factors. High BMI
likely reflects high BFP rather than high muscle mass in
our female, whereas men exhibited both increase in
muscle mass and fat percentages in parallel to increase
BMI. Skeletal muscle is the main site for insulin medi-
ated glucose disposal, some investigators hypothesized
that low muscle mass may be associated with insulin re-
sistance and cardiovascular risks [16].
Table 1 Demographic and laboratory features of study patients
according to gender
Parameters Female (n = 60) Male (n = 60) p value
Demographic characteristics
Age (yr) 44 ± 9 43 ± 10 ns
BMI (kg/m2) 28.4 ± 1.8 26.3 ± 3.6 p < 0.05
WHR 88 ± 10 82 ± 9 p < 0.05
BFP % 38.8 ± 11,8 32,6 ± 12,0 p < 0.05
SBP(mm Hg) 142.8 ± 12.8 136.4 ± 10,8 p < 0.05
DBP (mm Hg) 88.5 ± 10.0 83,9 ± 11,1 p < 0.05
Blood analysis
Glucose (mg/dl) 97.6 ± 9.5 99.5 ± 10.3 ns
Creatinin (mg/dl) 0.86 ± 0.14 0.86 ± 0.13 ns
LDL (mg/dl) 125.7 ± 32.3 118.5 ± 36.2 ns
Triglyceride (mg/dl) 164 ± 92 151 ± 111 ns
CRP (mg/dl) 3.1 ± 2.1 2.3 ± 1.7 ns
Hb (g/dl) 13.2 ± 0.9 14.3 ± 1.3 p < 0.05
Hct (%) 40.7 ± 3.8 42.2 ± 3.8 p < 0.05
Leukocyte count (per μL) 6.1 ± 1.9 5.9 ± 2.0 ns
PLT (per ml) 248.6 ± 60.0 272.8 ± 65.0 ns
LV mass/height2.7, g/m 94,8 ± 13,1 89,2 ± 14,6 p < 0.05
LV mass/BFP, g/kg 2,44 ± 0.99 2,73 ± 1.03 p < 0.05
BMI body mass ındex; WHR waist-to-hip ratio; BFP body fat percentage; SBP
systolc blood pressure; DBP diastolic blood pressure; LDL low density lipoprotein;
CRP C-reactive protein; Hb hemoglobulin; Hct hematocrite; PLT platelet
Table 2 Comparison of clinical and laboratory values of patients according to BFP tertiles
Parameters Group 1 Group 2 Group 3 p
BFP≤ 26 (n = 30) BFP = 26-48 (n = 60) BFP≥ 48 (n = 30)
Age 42.6 ± 4.2 44.4 ± 5.1 46.2 ± 3.1 p < 0.05
BMI 25.9 ± 2.1 27.1 ± 1.2 29.1 ± 1.6 p < 0.05
Triglyceride (mg/dL) 156 ± 101 157 ± 100 159 ± 112 p < 0.05
Leukocyte (per μL) 5.7 ± 2.1 5.9 ± 1.9 6.0 ± 2.0 p < 0.05
CRP 3.2 ± 1.7 4.2 ± 2.0 6.7 ± 2.1 p < 0.05
LVMI 88.9 ± 13.1 92.6 ± 10.1 95.2 ± 8.9 p < 0.05
BMI body mass ındex; WHR waist-to-hip ratio; BFP body fat percentage; CRP C-reactive protein; LVMI left ventruculare mass ındex
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The associations of BFP were demonstrated by the
multivariate analysis. Relation between body fat distrubi-
tion and CVD is in line with our prior findings in HD
patients [17]. Furthermore, we demonstrated that this
association is present in a population of hypertensive,
non-diabetic patients. Several studies have reported that
WHR was associated with albuminuria and BP both irre-
spective of BMI [18, 19]. In the current study, however,
we have not found a robust association between WHR
and albuminuria, possibly because of the very low albu-
minuria excretion rates, which reflect the strict inclusion
criteria of these new diagnosed hypertensive patients.
High BFP group were older, and had higher BMI, and
poor inflammatory profile in terms of higher levels of
CRP. BFP was another factor that contributed to inflam-
mation and vascular complications. An increase in adi-
pose tissue results in the infiltration of macrophages and
enhanced inflammation [20]. Moreover, it is associated
with increased proinflammatory cytokines (IL-6, TNF-a)
that contribute to atherosclerosis and CVD in high-fat
composition population [20, 21]. Thus, inflammation
play a role in classically initiated vascular injury, while at
the same time, fat mass may independently initiate or
propagate inflammation and vascular injury [22]. In this
study, BMI and BFP increased together and cardiovascu-
lar risks were higher in high-BMI and high-BFP groups.
On the contrary, increase in muscle mass could be pro-
tective against inflammation.
We have used LVMI instead of LVM in our study.
Recent guideline advocate the use of indexed LV mass
instead of measurements provided by septal thickness
only. In a large cohort study of unselected adult outpa-
tients referred to the echocardiography laboratory, the
measurements of indexed LV mass applying the ASE/
EAE recommended cut-offs yielded remarkable dis-
crepancy in the diagnosis of LVH severity and offered
prognostic information beyond that provided by septal
thickness only criteria [23].
Several mechanisms may play a role in the deleterious
effects of central fat accumulation on atherosclerosis,
such as oxidative stress and inflammation by up regula-
tion of pro-inflammatory adipokines and cytokines [24].
Furthermore, central fat is associated with dyslipidemia
and inflammation parameters most likely in mutual
interaction [25]. The combination of higher WHR and
BFP indicate a high post-glomerular efferent arteriolar
tone that can affect renal sodium handling [26]. We
propose that BFP-indexed partition values of LVH be de-
rived in other populations and that the prognostic sig-
nificance of these values, including that in subgroups
such as the obese, be evaluated in prospective studies.
The main limitation of our study is the small sample
size for calculation of predictors in multiple regression
analysis.
Conclusions
In conclusion, BFP was associated with higher LVMI, in
hypertensive persons. Of note, this association was
dependent of BMI. BFP seems physiologically appropriate
for LV mass indexation. Its use results in significantly lower
proportions of individuals with LVH in the population, in
particular among hypertensive and the obese patients
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